Insider trades
Tak Paul Peter, CEO of Candel Therapeutics CADL, has filed 0 purchases and 7 sales on the open market. The latest trade was on 01/26.
Tak Paul Peter
CEO
- Company
- Candel Therapeutics CADL
- First filing
- 23/05/02
- Trades
- 15 trades
- Buys / sales
- 0 / 7
- 12-month net buying
- No record
- Last trade
- 01/26
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
CADL | Open-market sale10b5-1 plan | 25/03/18–25/03/19 | 25/03/20 | 26,172 sh2 trades | $8.77avg. | $229,620.44 | −10.4% |
| Open-market sale | 25/01/15 | 25/01/17 | 21,704 sh | $7.23 | $156,919.92 | −7.9% | |
| Open-market sale | 25/01/08 | 25/01/10 | 21,172 sh | $8.22 | $174,033.84 | −7.2% | |
| Open-market sale | 24/11/29 | 24/12/03 | 48,847 sh | $4.56 | $222,742.32 | −14.2% | |
| Open-market sale | 24/07/17 | 24/07/19 | 22,528 sh | $6.47 | $145,756.16 | −6.4% | |
| Open-market sale | 24/07/11 | 24/07/15 | 20,293 sh | $5.97 | $121,149.21 | −5.4% |